StockWatch
·
Medical/Dental Instruments
Quarterly ResultAug 4, 2026, 03:39 PM

InfuSystem Q2 Net Income +24% to $3.23M; Approves $20M Buyback

AI Summary

InfuSystem Holdings, Inc. reported strong financial performance for the second quarter and first six months of 2026. Net income for Q2 increased 24.3% to $3.23 million, with basic EPS rising to $0.16. For the six months ended June 30, net income soared 82.1% to $4.25 million, and basic EPS reached $0.21. The company's Board of Directors also approved a new $20.0 million share repurchase program, and the maturity date for its Revolving Credit Facility was extended to July 15, 2030.

Key Highlights

  • Q2 2026 net income increased 24.3% to $3.23 million from $2.60 million in Q2 2025.
  • Q2 2026 basic EPS rose 33.3% to $0.16, up from $0.12 in Q2 2025.
  • Six-month 2026 net income surged 82.1% to $4.25 million compared to $2.33 million in the prior year.
  • Six-month 2026 basic EPS increased 90.9% to $0.21 from $0.11 in the same period last year.
  • Q2 2026 net revenues grew 2.6% to $36.93 million from $36.00 million in Q2 2025.
  • Board approved a new $20.0 million share repurchase program through June 30, 2028.
  • Revolving Credit Facility maturity date extended to July 15, 2030.
  • Cash and cash equivalents stood at $0.96 million as of June 30, 2026, down from $3.19 million at year-end 2025.